Inhibition of tumour necrosis factor-α in patients with chronic hepatitis C infection

By Zavos C.   Kountouras J.   Zavos N.   Chatzopoulos D.  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 283-283

Springer Publishing Company

Access to resources Recommend Favorite

Tumour necrosis factor-α blockers: potential limitations in the management of advanced endometriosis? A Case Report

By Shakiba Khashayar   Falcone Tommaso  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2417-2420

Oxford University Press

Access to resources Recommend Favorite

Change in Gait Deviation Index after anti-tumour necrosis factor-α treatment in individuals with rheumatoid arthritis: a pilot study

By Broström EW   Esbjörnsson A-C   Heideken J von   Larsson P   Wretenberg P   Iversen M  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 5, 2013-10 ,pp. : 356-361

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of sL-selectin and tumour necrosis factor-α in children with type 1 diabetes mellitus

By Dursun H.   Cinaz P.   Bideci A.   Guven A.   Aybay C.   Elbeg S.  

Acta Diabetologica, Vol. 44, Iss. 1, 2007-03 ,pp. : 1-5

Springer Publishing Company

Access to resources Recommend Favorite

Iron Overload Decreases the Protective Effect of Tumour Necrosis Factor-α on Rat Hepatocytes Exposed to Oxidative Stress

By Hagen K.   Eckes K.   Melefors Ö.   Hultcrantz R.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 6, 2002-06 ,pp. : 725-731

Informa Healthcare

Access to resources Recommend Favorite